Main Content

“2020health is an important and thoughtful contributor to the health debate”

Dr Sarah Wollaston MP, Chairman, Health Select Committee

 
 

June

2020health News Prospect Think Tank Awards 2015

Prospect Think Tank Awards 2015

Last night at the Prospect Think Tank Awards, 2020health were delighted to be shortlisted to the top 3, for the UK Social Policy Award.

Prospect said: 2020health was included on the short list this year, with the judges pointing to its “Imaginative approach to the effect of social circumstances, poverty and education on health, with implications for health policy—this is ground-breaking work.”

Julia met with Bronwen Maddox (editor of Prospect and former Foreign Affairs Editor of The Times) afterwards who said the judges were really impressed with 2020health's work.

Congratulations to The Resolution Foundation who were the winners in the Social Policy category and the IFS who won overall.
read on Prospect Think Tank Awards 2015

BBC Radio London 94.9 Duty of Candour

Julia Manning, Chief Executive of 2020health spoke on BBC Radio London about the new duty of candour guidelines. read on Duty of Candour

Sky News New NICE guidelines for doctors & patients could transform cancer care in UK

New NICE guidelines for doctors & patients could transform cancer care in UK

Julia Manning, Chief Executive, 2020health spoke on Sky News about the new NICE guidelines to encourage GP's to screen patients showing possible signs of cancer, quicker and earlier. GP's may be given tools to carry out basic diagnostic tests in surgeries. Julia pointed out that the previous advice was 10 years out of date so the new guidelines are welcome and the public can only benefit, though they must of course have realistic expectations. read on New NICE guidelines for doctors & patients could transform cancer care in UK

BBC Radio 5 Live Combining Cancer Drugs

Julia Manning, Chief Executive of 2020health spoke on BBC Radio Five's Afternoon Edition about the new clinical trial combining two cancer drugs. Julia explained how Cancer costs not only the NHS approx 5 billion each year but around 18.3 billion to the economy in general due to loss of productivity and such. She discussed how the 'Cancer Drugs Fund' is controversial because it is only for Cancer Drugs and some believe it demonstrates a lack of value for money. One of the Cancer drugs used in the trial was approved by NICE and one wasn't so would therefore need to be funded by the 'Cancer Drugs Fund' to make it nationally available. Though it has been found not all Cancer drugs are available to all areas of the country. Julia believes politicians need to manage expectations and lead the way in involving the public in a debate about the price of extending life. read on Combining Cancer Drugs